These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18270850)

  • 21. Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.
    Nicaise Roland P; Grootenboer Mignot S; Bruns A; Hurtado M; Palazzo E; Hayem G; Dieudé P; Meyer O; Chollet Martin S
    Arthritis Res Ther; 2008; 10(6):R142. PubMed ID: 19077182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.
    Besada E; Nikolaisen C; Nossent H
    Clin Exp Rheumatol; 2011; 29(1):85-8. PubMed ID: 21269572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.
    Al-Jarallah K; Shehab D; Al-Attiyah R; Al-Azmi W; Al-Fadli A; Zafar Haider M; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2012 Sep; 18(9):1655-62. PubMed ID: 22114016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders.
    Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
    J Rheumatol; 2009 Dec; 36(12):2670-4. PubMed ID: 19884278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
    Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
    Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis.
    Sghiri R; Bouajina E; Bargaoui D; Harzallah L; Fredj HB; Sammoud S; Ghedira I
    Rheumatol Int; 2008 Nov; 29(1):59-62. PubMed ID: 18496693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
    Qu SJ; Ye H; Jia RL; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay.
    Renger F; Bang H; Feist E; Fredenhagen G; Natusch A; Backhaus M; Burmester GR; Egerer K
    Arthritis Res Ther; 2010; 12(3):R120. PubMed ID: 20569500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis.
    Koivula MK; Heliövaara M; Rissanen H; Palosuo T; Knekt P; Immonen H; Risteli J
    Ann Rheum Dis; 2012 Oct; 71(10):1666-70. PubMed ID: 22419777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.
    Coenen D; Verschueren P; Westhovens R; Bossuyt X
    Clin Chem; 2007 Mar; 53(3):498-504. PubMed ID: 17259232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis: A meta-analysis.
    Lee YH; Bae SC; Song GG
    Z Rheumatol; 2015 Dec; 74(10):911-8. PubMed ID: 26111961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two assays to determine anti-citrullinated peptide antibodies in rheumatoid arthritis in relation to other chronic inflammatory rheumatic diseases: assaying anti-modified citrullinated vimentin antibodies adds value to second-generation anti-citrullinated cyclic peptides testing.
    Díaz-Toscano ML; Olivas-Flores EM; Zavaleta-Muñiz SA; Gamez-Nava JI; Cardona-Muñoz EG; Ponce-Guarneros M; Castro-Contreras U; Nava A; Salazar-Paramo M; Celis A; Fajardo-Robledo NS; Corona-Sanchez EG; Gonzalez-Lopez L
    Biomed Res Int; 2014; 2014():198198. PubMed ID: 25025037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies against a mutated citrullinated vimentin in patients with rheumatoid arthritis.
    Nigm DA; Abdel-Lateef HH; Hashim J; Kamal D
    Egypt J Immunol; 2022 Oct; 29(4):184-194. PubMed ID: 36208047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].
    Zhang L; Ru J; Jie X; Che G; Jin X; Li X
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?
    Zhu JN; Nie LY; Lu XY; Wu HX
    Clin Chem Lab Med; 2019 Oct; 57(11):1668-1679. PubMed ID: 31141478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis.
    Ishigooka N; Fujii T; Abe H; Murakami K; Nakashima R; Hashimoto M; Yoshifuji H; Tanaka M; Ito H; Ohmura K; Morita S; Mimori T
    Mod Rheumatol; 2020 May; 30(3):450-457. PubMed ID: 31116051
    [No Abstract]   [Full Text] [Related]  

  • 38. Mutated citrullinated vimentin antibodies in rheumatoid arthritis.
    Kuna AT
    Clin Chim Acta; 2012 Jan; 413(1-2):66-73. PubMed ID: 22037509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of antibodies to modified citrullinated vimentin in early rheumatoid arthritis.
    Sizova L
    Hum Immunol; 2012 Apr; 73(4):389-92. PubMed ID: 22333689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
    Syversen SW; Goll GL; van der Heijde D; Landewé R; Lie BA; Odegård S; Uhlig T; Gaarder PI; Kvien TK
    Ann Rheum Dis; 2010 Feb; 69(2):345-51. PubMed ID: 19648126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.